Sort by
Refine Your Search
-
at Northeastern University invites applications for a Postdoctoral Research Associate or more senior position. The position is to begin Summer or Fall 2025 for a term of 2-3 years, with yearly renewals based upon
-
a two-year Global Medical Information and Communications fellowship, based in New Jersey. About Pacira Pacira BioSciences, Inc. is a leading provider of non-opioid pain management and regenerative
-
, empirical and structure-based target design, synthetic chemistry and troubleshooting. Our main focuses are to improve the potency/efficacy and physicochemical as well as pharmacokinetics properties of the hit
-
Researcher will be based out of either the Boston, MA or Portland, ME campus and conduct applied research, prepare work for submission to journal/conference publications, contribute to extramural funding
-
, and scholarly activities. In partnership with Northeastern University, Pacira BioSciences is offering a two-year Global Medical Information and Communications fellowship, based in New Jersey. About
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Patient Safety and Risk Management fellowship, based in Cambridge, MA. About
-
Derived Therapy fellowship, based in Cambridge, MA. About Takeda Takeda has been translating science into breakthrough medicines for 240 years. Every step of the way, our teams have worked together
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Medical Information fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
, and scholarly activities. In partnership with Northeastern University, Apellis Pharmaceuticals is offering a two-year Global Medical Affairs fellowship, based in Waltham, MA. About Apellis
-
Global Medical Information fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative